News Roundup | CDC Green lights Pfizer-BioNTech mRNA Booster Dose for Children Aged 5 to 11 Years

Join The Conversation! | https://trialsitenews.com/
The Centers for Disease Control and Prevention (CDC) convened a meeting of their Advisory Committee on Immunization Practices (ACIP) after an Emergency Use Authorization (EUA) amendment was issued by the U.S Food and Drug Administration (FDA) on May 17. This amendment expands the eligibility for the Pfizer-BioNTech COVID-19 vaccine booster dose for children ages 5 to 11 years at least five months after completion of a primary series. Responding to the policy question posed by the CDC, and “based on the balance of benefits and risks,” ACIP voted in favor of the following Interim Recommendation: “A single Pfizer-BioNTech COVID-19 vaccine booster dose is recommended for persons ages 5-11 years at least 5 months after the primary series, under the FDA’s Emergency Use Authorization.”

Article Link | https://www.trialsitenews.com/a/cdc-greenlights-pfizer-biontech-mrna-booster-dose-for-children-aged-5-to-11-years-on-limited-evidence-33d64f9e